Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000243860

Medchemexpress LLC Samuraciclib hydrochloride | 1805789-54-1 | MFCD31657343 | 99.9% | 430.97 g/mol | C22H31ClN6O | 100 MG
SDP

Supplier:  Medchemexpress LLC HY103712A100MG

Encompass_Preferred

Samuraciclib hydrochloride is a potent, selective, ATP-competitive, and orally active inhibitor of cyclin-dependent kinase 7 (CDK7) used in preclinical research. It inhibits proliferation of cancer cell lines and has demonstrated anti-tumor activity in vitro, making it a tool compound for studying CDK7-related transcriptional control and apoptosis pathways.

  • Potent, selective CDK7 inhibition (IC50 ~41 nM).
  • Orally active compound suitable for in vitro and preclinical studies.
  • Shown to inhibit cancer cell growth (GI50 0.2-0.3 μM in breast cancer lines).
  • Applicable for research on transcriptional regulation and apoptosis mechanisms.
  • Supplied as a stable solid with recommended refrigerated storage to maintain integrity.

Catalog No. 50-002-43860


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.